Defective Intracellular Insulin/IGF-1 Signaling Elucidates the Link Between Metabolic Defect and Autoimmunity in...

Area of Science:

• Immunodermatology
• Metabolic disorders
• Cellular biology

Background:

• Vitiligo is characterized by white maculae, resulting from immune attacks on melanocytes.
• The precise trigger for immune cell activation in vitiligo remains unclear.
• Growing evidence suggests a link between altered mitochondrial metabolism and vitiligo pathogenesis, potentially involving systemic metabolic issues like insulin resistance.

Purpose of the Study:

• To investigate the role of insulin and IGF-1 signaling in vitiligo pathogenesis.
• To determine if cellular insulin resistance is present in non-lesional vitiligo skin.
• To explore the impact of metabolic dysfunction on immune cell activation in vitiligo.

Main Methods:

• Comparison of Ins/IGF-1 intracellular signaling pathways in dermal and epidermal cells from non-lesional vitiligo skin versus healthy donors.
• Analysis of glucose uptake, phosphorylation of key signaling molecules (S6, IRS1), and cellular responses to Ins/IGF-1 stimulation.
• Assessment of cellular energy status, including ATP levels, catabolic processes, and oxidative stress.

Main Results:

• Vitiligo cells exhibit intensified glucose uptake and chronic phosphorylation of S6 and IRS1, indicative of cellular insulin resistance.
• Ins/IGF-1 stimulation resulted in significantly compromised mitogenic and metabolic activities in vitiligo cells.
• Vitiligo skin cells displayed energetic disequilibrium (low ATP, activated catabolism, oxidative stress), particularly pronounced in keratinocytes.

Conclusions:

• The findings support the involvement of insulin and IGF-1 resistance, coupled with dysfunctional glucose metabolism, in vitiligo pathogenesis.
• Impaired intracellular metabolic activities in vitiligo keratinocytes, especially upon Ins/IGF-1 stimulation, lead to a pro-inflammatory phenotype.
• This aberrant phenotype may contribute to the recruitment of immune cells, driving the inflammatory processes observed in vitiligo.